Terms: = Kidney tumors AND LEF1, TCF1ALPHA, 51176, ENSG00000138795, Q9UJU2, DKFZp586H0919
16 results:
1.
Li N; Chu J; Hu K; Zhang H; Li N; Chu JF; Hu KY; Zhang HY
J Biosci; 2023; 48():. PubMed ID: 37309171
[TBL] [Abstract] [Full Text] [Related]
2. Construction and validation of an autophagy-related long non-coding RNA signature to predict the prognosis of kidney renal papillary cell carcinoma.
Kang Z; Yang J
J Investig Med; 2022 Oct; 70(7):1536-1544. PubMed ID: 35725019
[TBL] [Abstract] [Full Text] [Related]
3. Peroxisome proliferator-activated receptor γ (PPARγ) suppresses the proliferation and metastasis of patients with urothelial carcinoma after renal transplantation by inhibiting lef1/β-catenin signaling.
Shang D; Liu Y; Zhang J; Hu X
Bioengineered; 2020 Dec; 11(1):1350-1367. PubMed ID: 33289586
[TBL] [Abstract] [Full Text] [Related]
4. Transforming growth factor-β1 enhances proliferative and metastatic potential by up-regulating lymphoid enhancer-binding factor 1/integrin αMβ2 in human renal cell carcinoma.
Liu Y; Shang D
Mol Cell Biochem; 2020 Feb; 465(1-2):165-174. PubMed ID: 31848806
[TBL] [Abstract] [Full Text] [Related]
5. Failed immune responses across multiple pathologies share pan-tumor and circulating lymphocytic targets.
Monette A; Morou A; Al-Banna NA; Rousseau L; Lattouf JB; Rahmati S; Tokar T; Routy JP; Cailhier JF; Kaufmann DE; Jurisica I; Lapointe R
J Clin Invest; 2019 Mar; 129(6):2463-2479. PubMed ID: 30912767
[TBL] [Abstract] [Full Text] [Related]
6. Transcriptional alterations in hereditary and sporadic nonfunctioning pancreatic neuroendocrine tumors according to genotype.
Keutgen XM; Kumar S; Gara SK; Boufraqech M; Agarwal S; Hruban RH; Nilubol N; Quezado M; Finney R; Cam M; Kebebew E
Cancer; 2018 Feb; 124(3):636-647. PubMed ID: 29149451
[TBL] [Abstract] [Full Text] [Related]
7. Highly Expressed Antisense Noncoding RNA in the INK4 Locus Promotes Growth and Invasion of Renal Clear Carcinoma Cells via the β-Catenin Pathway.
Li Q; Tian Y; Hu G; Liang Y; Bai W; Li H
Oncol Res; 2017 Sep; 25(8):1373-1382. PubMed ID: 28251886
[TBL] [Abstract] [Full Text] [Related]
8. Cyclin D1 as a therapeutic target of renal cell carcinoma- a combined transcriptomics, tissue microarray and molecular docking study from the Kingdom of Saudi Arabia.
Karim S; Al-Maghrabi JA; Farsi HM; Al-Sayyad AJ; Schulten HJ; Buhmeida A; Mirza Z; Al-Boogmi AA; Ashgan FT; Shabaad MM; NourEldin HF; Al-Ghamdi KB; Abuzenadah A; Chaudhary AG; Al-Qahtani MH
BMC Cancer; 2016 Sep; 16(Suppl 2):741. PubMed ID: 27766950
[TBL] [Abstract] [Full Text] [Related]
9. [MiRNA-381 inhibits the invasion of renal carcinoma and
the underlying mechanisms].
Chen B; Liu B
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2015 Oct; 40(10):1053-9. PubMed ID: 26541837
[TBL] [Abstract] [Full Text] [Related]
10. Expression and proliferation-promoting role of lymphoid enhancer-binding factor 1 in human clear cell renal carcinoma.
Shang D; Bi R; Han T; Wang D; Tian Y; Liu Y
Cancer Invest; 2014 Aug; 32(7):368-74. PubMed ID: 24897388
[TBL] [Abstract] [Full Text] [Related]
11. Expression of secreted frizzled-related protein 1 and 3, T-cell factor 1 and lymphoid enhancer factor 1 in clear cell renal cell carcinoma.
Nikuševa-Martić T; Serman L; Zeljko M; Vidas Z; Gašparov S; Zeljko HM; Kosović M; Pećina-Šlaus N
Pathol Oncol Res; 2013 Jul; 19(3):545-51. PubMed ID: 23572277
[TBL] [Abstract] [Full Text] [Related]
12. Gene expression profiling of the synergy of 5-aza-2'-deoxycytidine and paclitaxel against renal cell carcinoma.
Han T; Shang D; Xu X; Tian Y
World J Surg Oncol; 2012 Sep; 10():183. PubMed ID: 22950635
[TBL] [Abstract] [Full Text] [Related]
13. 5-aza-2'-deoxycytidine enhances susceptibility of renal cell carcinoma to paclitaxel by decreasing lef1/phospho-β-catenin expression.
Shang D; Liu Y; Xu X; Han T; Tian Y
Cancer Lett; 2011 Dec; 311(2):230-6. PubMed ID: 21880414
[TBL] [Abstract] [Full Text] [Related]
14. Kaiso is a bimodal modulator for Wnt/beta-catenin signaling.
Iioka H; Doerner SK; Tamai K
FEBS Lett; 2009 Feb; 583(4):627-32. PubMed ID: 19166851
[TBL] [Abstract] [Full Text] [Related]
15. Synergistic cooperation between the AP-1 and LEF-1 transcription factors in activation of the matrilysin promoter by the src oncogene: implications in cellular invasion.
Rivat C; Le Floch N; Sabbah M; Teyrol I; Redeuilh G; Bruyneel E; Mareel M; Matrisian LM; Crawford HC; Gespach C; Attoub S
FASEB J; 2003 Sep; 17(12):1721-3. PubMed ID: 12958188
[TBL] [Abstract] [Full Text] [Related]
16. Mutations of the beta- and gamma-catenin genes are uncommon in human lung, breast, kidney, cervical and ovarian carcinomas.
Ueda M; Gemmill RM; West J; Winn R; Sugita M; Tanaka N; Ueki M; Drabkin HA
Br J Cancer; 2001 Jul; 85(1):64-8. PubMed ID: 11437403
[TBL] [Abstract] [Full Text] [Related]
